DocuSign, Inc. (NASDAQ:DOCU) to Post FY2027 Earnings of $0.83 Per Share, Zacks Research Forecasts

DocuSign, Inc. (NASDAQ:DOCU) – Equities researchers at Zacks Research issued their FY2027 earnings per share estimates for shares of DocuSign in a research note issued to investors on Thursday, March 28th. Zacks Research analyst R. Department forecasts that the company will post earnings per share of $0.83 for the year. The consensus estimate for DocuSign’s current full-year earnings is $0.81 per share.

A number of other equities research analysts also recently weighed in on the company. Piper Sandler reduced their target price on DocuSign from $57.00 to $50.00 and set a “neutral” rating on the stock in a report on Friday, December 8th. TheStreet upgraded DocuSign from a “d+” rating to a “c-” rating in a research note on Tuesday, December 19th. Morgan Stanley raised DocuSign from an “underweight” rating to an “equal weight” rating and raised their target price for the stock from $49.00 to $64.00 in a research report on Tuesday, January 16th. Wells Fargo & Company lowered their target price on DocuSign from $55.00 to $45.00 and set an “underweight” rating for the company in a research report on Monday, February 5th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $50.00 target price on shares of DocuSign in a research report on Friday, January 12th. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $58.33.

DocuSign Stock Performance

Shares of DOCU stock opened at $59.55 on Friday. The stock’s fifty day moving average price is $55.92 and its two-hundred day moving average price is $50.35. The company has a market cap of $12.23 billion, a PE ratio of 165.42, a P/E/G ratio of 5.52 and a beta of 0.87. DocuSign has a fifty-two week low of $38.11 and a fifty-two week high of $64.76.

Insider Activity

In other news, CEO Allan C. Thygesen sold 7,420 shares of the firm’s stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $58.19, for a total value of $431,769.80. Following the completion of the sale, the chief executive officer now directly owns 119,447 shares in the company, valued at approximately $6,950,620.93. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other DocuSign news, CEO Allan C. Thygesen sold 7,420 shares of DocuSign stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $58.19, for a total transaction of $431,769.80. Following the completion of the transaction, the chief executive officer now owns 119,447 shares in the company, valued at approximately $6,950,620.93. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Allan C. Thygesen sold 7,680 shares of DocuSign stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $61.27, for a total value of $470,553.60. Following the transaction, the chief executive officer now owns 111,767 shares of the company’s stock, valued at approximately $6,847,964.09. The disclosure for this sale can be found here. Insiders sold a total of 45,491 shares of company stock worth $2,604,469 in the last three months. Company insiders own 17.80% of the company’s stock.

Hedge Funds Weigh In On DocuSign

Hedge funds and other institutional investors have recently modified their holdings of the business. Nelson Van Denburg & Campbell Wealth Management Group LLC boosted its stake in shares of DocuSign by 440.0% in the 1st quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 270 shares of the company’s stock worth $28,000 after buying an additional 220 shares during the last quarter. Capital Analysts LLC boosted its stake in shares of DocuSign by 781.7% in the 4th quarter. Capital Analysts LLC now owns 529 shares of the company’s stock worth $31,000 after buying an additional 469 shares during the last quarter. BluePath Capital Management LLC purchased a new position in shares of DocuSign in the 3rd quarter worth approximately $32,000. McGlone Suttner Wealth Management Inc. purchased a new position in shares of DocuSign in the 4th quarter worth approximately $32,000. Finally, Virtus Fund Advisers LLC purchased a new position in shares of DocuSign in the 4th quarter worth approximately $33,000. Hedge funds and other institutional investors own 77.64% of the company’s stock.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides DocuSign e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.